GAL and cancer: High GAL1 expression was significantly associated with a poor recurrence-free survival (RFS; p = 0.028; Figure 2G) and cancer-specific survival (CSS; p = 0.025; Figure 2H); hence, RFS and CSS were lower in the GAL-high group than in the GAL1-low group.